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Abstract: Introduction: Intraindividual variability (IIV) in motor performance 
has been shown to predict future cognitive decline. The apolipoprotein E-
epsilon 4 (APOE-ε4) allele is also a well-established risk factor for memory 
decline. Here, we present novel findings examining the influence of the APOE-
ε4 allele on the performance of asymptomatic healthy elders in comparison to 
individuals with amnestic MCI (aMCI) on a fine motor synchronization, paced 
finger-tapping task (PFTT). Method: Two Alzheimer’s disease (AD) risk 
groups, individuals with aMCI (n = 24) and cognitively intact APOE-ε4 carriers 
(n = 41), and a control group consisting of cognitively intact APOE-ε4 non-
carriers (n = 65), completed the Rey Auditory Verbal Learning Test and the 
PFTT, which requires index finger tapping in synchrony with a visual stimulus 
(inter-stimulus interval = 333 milliseconds). Results: Motor timing IIV, as 
reflected by the standard deviation of the inter-tap interval (ITI), was greater 
in the aMCI group relative to the two groups of cognitively intact elders; in 
contrast, all three groups had statistically equivalent mean ITI. No significant 
IIV differences were observed between the asymptomatic APOE-ε4 carriers 
and non-carriers. Poorer episodic memory performance was associated with 
greater IIV, particularly in the aMCI group. Conclusions: Results suggest that 
increased IIV on a fine motor synchronization task is apparent in aMCI. This 
IIV measure was not sensitive in discriminating older asymptomatic 
individuals at genetic risk for AD from those without such a genetic risk. In 
contrast, episodic memory performance, a well-established predictor of 
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cognitive decline in preclinical AD, was able to distinguish between the two 
cognitively intact groups based on genetic risk. 
 
Keywords: intraindividual variability, apolipoprotein ε4, motor timing, 
episodic memory, aging, mild cognitive impairment 
 
Introduction 
 
The increased incidence of the apolipoprotein E-epsilon 4 
(APOE-ε4) allele in mild cognitive impairment (MCI) and Alzheimer’s 
disease (AD) is well established (Caselli et al., 2007; Corder et al., 
1993). There is also evidence that the presence of an APOE-ε4 allele is 
a risk factor for conversion to MCI and AD in healthy older adults (see 
Small, Rosnick, Fratiglioni, & Backman, 2004; Wisdom, Callahan, & 
Hawkins, 2011 for reviews). As a result, there is considerable interest 
in identifying reliable cognitive markers that discriminate APOE-ε4 
carriers from non-carriers during the preclinical stage. Episodic 
memory, executive functions, and attention are the most frequent 
domains studied (Bondi, Salmon, Galasko, Thomas, & Thal, 1999; 
Bookheimer et al., 2000; Rosen, Bergeson, Putnam, Harwell, & 
Sunderland, 2002; Small et al., 2000). 
 
These previous studies almost exclusively compared mean 
scores between APOE-ε4 carriers and non-carriers. More recently, 
there has been considerable interest in the possibility that 
intraindividual variability (IIV) in task performance may be informative 
in examining cognitive functioning in older adults. Support for this 
notion is derived from studies showing that older adults exhibit greater 
fluctuations in cognitive performance and greater variability in reaction 
time (RT) tasks compared to younger adults (Bunce, MacDonald, & 
Hultsch, 2004; Hilborn, Strauss, Hultsch, & Hunter, 2009; Hultsch, 
MacDonald, & Dixon, 2002). For example, Hultsch, MacDonald, and 
Dixon (2002) observed greater within-person RT variability in older 
adults (ages 54-94 years) compared to younger adults (ages 17-36 
years) using simple, choice, and lexical and semantic decision tasks. 
Importantly, these results remained even when group differences in 
response speed were statistically controlled. 
 
In addition, IIV appears to predict future cognitive decline in 
asymptomatic elders (Bielak, Hultsch, Strauss, Macdonald, & Hunter, 
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2010a, 2010b; Lovden, Li, Shing, & Lindenberger, 2007; MacDonald, 
Hultsch, & Dixon, 2003; Sugarman et al., 2014). For example, 
increased IIV in simple, choice, and switching RT tasks among healthy 
elders was associated with a greater likelihood of being classified with 
greater cognitive impairment five years later (Bielak et al., 2010a). IIV 
in various RT tasks has also discriminated cognitively intact elders 
from symptomatic individuals, including those with MCI (Christensen 
et al., 2005; Dixon et al., 2007) and AD (Duchek et al., 2009; 
Tractenberg & Pietrzak, 2011). RT IIV also differentiated individuals 
with mild MCI compared to moderate MCI, and has been shown to be a 
better predictor of cognitive status than mean RT speed (Dixon et al., 
2007). 
 
To date, few studies have examined the relationship between 
estimates of IIV and the presence/absence of the APOE-ε4 allele in 
asymptomatic elders. Duchek et al. (2009) compared group 
differences in healthy elders with and without the APOE-ε4 allele and 
individuals with early stage AD on IIV measures derived from three 
attention tasks (Stroop, Simon, task switching). No significant 
differences in overall IIV measures were reported between the healthy 
APOE-ε4 carrier and non-carrier groups, with the one exception being 
an IIV measure derived from Stroop incongruent trials. In a more 
recent study, Kalin et al. (2014) examined within- and across-domain 
IIV in healthy elders with and without the APOE-ε4 allele, individuals 
with MCI, and those diagnosed with AD. Measures spanning several 
cognitive domains, including working memory, semantic memory, and 
executive functioning were examined. There was no main effect across 
domains for IIV in healthy controls, MCI, or AD. However, healthy 
elders with the APOE-ε4 allele demonstrated significantly greater 
within-domain IIV in tasks of executive functioning compared to 
healthy elders without the allele, though the effect size was small (𝜂𝜂𝑝𝑝2 
=0.035). 
 
A growing body of research has demonstrated that individuals 
with MCI or early AD show increased variability in motor performance 
compared to healthy controls (Dodge, Mattek, Austin, Hayes, & Kaye, 
2012; Verghese et al., 2008). For example, using passive infrared 
sensors fixed on the ceiling of the homes of elderly participants, 
Dodge, Mattek, Austin, Hayes, and Kaye (2012) reported that 
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individuals with non-amnestic MCI were less likely than controls to 
exhibit trajectories of stable walking speed variability. Longitudinal 
studies have also demonstrated that increased IIV in motor functioning 
predicts future cognitive decline in asymptomatic individuals (Bangert 
& Balota, 2012; Verghese, Wang, Lipton, Holtzer, & Xue, 2007). 
However, the impact of the APOE-ε4 allele on motor functioning in the 
preclinical stage has not been previously reported. 
 
The purpose of the current investigation was to examine the 
influence of the APOE-ε4 allele on the performance of asymptomatic 
healthy elders in comparison to individuals with amnestic MCI (aMCI) 
on a fine motor synchronization, paced finger-tapping task (PFTT). A 
similar task has already been shown to discriminate individuals with 
early AD compared to healthy controls (Bangert & Balota, 2012). 
There were three specific objectives: (1) to compare mean inter-tap 
interval (ITI) performance on the PFTT across three groups of elders 
(cognitively intact APOE-ε4 non-carriers, cognitively intact APOE-ε4 
carriers, and individuals with aMCI); (2) to compare PFTT IIV, defined 
by the standard deviation of the ITI, across the three groups; (3) to 
examine the association of mean and IIV scores from the PFTT with 
scores from the Rey Auditory Verbal Learning Test (RAVLT; Rey, 
1958), an episodic memory measure of list learning. 
 
We predicted that IIV on the PFTT would distinguish between 
the three groups. Specifically, we predicted that the aMCI group would 
show greater IIV than the healthy asymptomatic groups, and the 
cognitively intact APOE-ε4 carriers would show higher IIV than APOE-
ε4 non-carriers. Further, we expected an inverse relationship (more 
variability associated with lower memory scores) between episodic 
memory performance on the RAVLT and IIV on the PFTT. 
 
Method 
 
Participants 
 
Cognitively intact individuals (n = 106) were recruited via 
newspaper advertisements placed in the greater Milwaukee area. 
Healthy participants were subsequently classified into two groups: 
APOE-ε4 negative (n = 65) and APOE-ε4 positive (n = 41). Twenty-
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four aMCI participants (9 APOE-ε4 negative; 15 APOE-ε4 positive) 
were also recruited from the Memory Disorders Clinic at the Medical 
College of Wisconsin (MCW). All participants completed a cognitive 
screening battery consisting of the Mini-Mental State Examination 
(MMSE; Folstein, Folstein, & McHugh, 1975) and Mattis Dementia 
Rating Scale-2 (DRS-2; Jurica, Leitten, & Mattis, 2001). The Lawton 
Instrumental Activities of Daily Living (IADL) Scale (Lawton & Brody, 
1969) and Geriatric Depression Scale (GDS; Yesavage et al., 1982) 
were also administered at study entry. 
 
Cognitively intact participants obtained a minimum score of 27 
on the MMSE and performed within 1.5 standard deviations of age-
appropriate means on the DRS-2 (total score) based on normative 
data from the test manual (Jurica et al., 2001). aMCI participants met 
diagnostic criteria based on Petersen’s criteria (Petersen, 2004) and 
were evaluated by a neurologist with expertise in dementia to rule out 
other possible bases for the memory impairment. All aMCI participants 
obtained scores greater than or equal to 23 on the MMSE, scored 
greater than 1.5 standard deviations below age-appropriate means on 
the DRS-2 (total score), and below 4 on the modified Hachinski 
Ischemic Scale. All participants obtained a minimum score of 4 (5-
point scale) on the IADL scale to rule out limitations in activities of 
daily living, and all participants scored less than 14 on the GDS to rule 
out moderate to severe depressive symptoms. 
 
Participants acknowledged no history of neurologic disease or 
other major medical illness and did not meet criteria for any Axis I 
psychiatric illness or substance abuse/dependence according to the 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition 
(DSMIV). All participants were right-handed based on the Edinburgh 
Handedness Inventory (Oldfield, 1971). Informed consent was 
obtained in accordance with the Declaration of Helsinki and 
institutional guidelines established by the MCW Human Subjects 
Review Committee. All participants received financial compensation. 
 
Genotyping 
 
Genotyping for the APOE-ε4 alleles (ε2, ε3, ε4) was determined 
using a polymerase chain reaction method described by Saunders et 
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al. (1996) . Deoxyribonucleic acid was isolated with the Gentra 
Systems Autopure LS for Large Sample Nucleic Acid Purification 
(O'Brien, Campbell, Morken, Bair, & Heath, 2001). The APOE-ε4 
negative group included participants with ε23 (n = 10) or ε33 (n = 55) 
genotype; the APOE-ε4 positive group included participants with ε24 
(n = 2), ε34 (n = 37), or ε44 (n = 2) genotype. The APOE genotyping 
distribution for MCI participants was: ε23 (n = 1), ε33 (n = 8), ε24 (n 
= 1), ε34 (n = 10) and ε44 (n = 4).  
 
Measures 
 
Episodic Memory 
All participants completed the RAVLT, a commonly used episodic 
memory measure. The RAVLT requires individuals to learn a list of 15 
words over five trials. After an interference trial, individuals complete 
an immediate recall trial, followed by a delayed recall trial 30 minutes 
later. Mean scores were analyzed for total number of words recalled 
across trials 1-5, immediate recall, and delayed recall. 
 
Paced Finger-Tapping Task 
 
All participants completed the PFTT while lying in a magnetic 
resonance imaging (MRI) scanner. Participants were instructed to tap a 
button box with their right index finger in synchrony with a visual 
flashing yellow and black checkerboard presented at a stimulus 
frequency of 3 Hertz. The PFTT was performed in a block design 
paradigm. Eight blocks of finger tapping alternated with periods of 
rest, during which participants viewed a black fixation cross in the 
center of a white background. Tapping blocks and periods of rest were 
each 12 seconds in duration. Based on the stimulus presentation 
frequency of 3 Hertz, a perfect synchronization score consisted of 36 
finger-taps per block for a total of 288 finger-taps with a mean inter-
tap interval (ITI) of 333 milliseconds (ms) over the course of the task. 
ITIs, measured in ms, were recorded using E-Prime software 
(Psychology Software Tools, Pittsburgh, PA). it is three standard 
deviations above or below each participant’s individual mean ITI score 
were considered outliers and were removed prior to data analysis. 
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Data Analyses 
 
PFTT measures include mean ITI performance based on a 
difference score from the target synchronization ITI of 333 ms (M-ITI) 
and a measure of IIV based on the within-subject standard deviation 
of ITIs (SD-ITI). Initial inspection of PFTT data using quantile-quantile 
(QQ) plots and tests of normality (i.e., skewness and kurtosis; 
Shapiro-Wilk statistic) revealed that PFTT indices (M-ITI and SD-ITI) 
were not normally distributed. Therefore, a reciprocal square root data 
transformation was performed on these measures to correct for 
normality violations. 
 
Group comparisons of demographics and cognitive screening 
measures (MMSE and DRS-2), RAVLT, and PFTT were applied using 
analyses of variance (ANOVAs), except for sex distribution, which was 
analyzed using a Pearson chi-square test. ANOVA post hoc tests 
include the Hochberg’s GT2 and Games-Howell corrections for 
homogeneity and heterogeneity of variance respectively, as well as 
unequal sample sizes. 
 
Preliminary data analyses between demographic variables and 
behavioral measures indicated significant negative correlations (range 
of r = -0.18 to -0.35; p’s < 0.05) between age and mean performance 
on the MMSE, RAVLT, and select DRS-2 indices. Age was also 
positively correlated with SD ITI on the PFTT (r = 0.17; p = 0.05), and 
education was positively correlated with the DRS-2 conceptualization 
subscale (r = 0.24; p = 0.007) and DRS-2 total score (r = 0.17; p = 
0.048). 
 
Taking these findings into account, ANOVAs for the MMSE, DRS-
2 initiation/perseveration subscale, RAVLT trials 1-5, RAVLT immediate 
recall, RAVLT delayed recall, and SD-ITI were performed using 
standardized residual scores based on regression analyses with age as 
a predictor. ANOVAs for the DRS-2 conceptualization subscale and 
DRS-2 total score were performed using standardized residual scores 
based on regression analyses with age and education as predictors. 
Partial correlations, with age as a covariate, were conducted to 
examine the association between RAVLT and PFTT performances 
across groups. 
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The aMCI group consisted of 24 participants (9 APOE-ε4 
negative and 15 APOE-ε4 positive). Preliminary t-test analyses 
between APOE-ε4 carriers and non-carriers within the aMCI group 
indicated no differences in age, education, episodic memory 
performance, or PFTT performance (p’s > 0.05). Therefore, the effect 
of the APOE-ε4 allele was not further analyzed within the aMCI group. 
Rather, individuals with aMCI were considered as a distinct group of 
participants with substantiated cognitive status beyond a prodromal 
stage of impairment based on diagnostic criteria (Petersen, 2004) and 
results of cognitive screening measures (i.e., MMSE, DRS-2). 
 
Results 
 
Demographics 
 
Group demographic statistics are shown in Table 1. There were 
no significant group differences in age, education, or sex distribution 
between groups (p’s > 0.05). 
 
Cognitive Screening Battery 
 
Table 1 shows significant omnibus group differences in mean 
performance on the MMSE and DRS subscales for the three groups. As 
expected, post-hoc analyses revealed that aMCI participants had 
significantly lower scores on the MMSE and most DRS-2 subscales (p’s 
< 0.05), but there were no significant differences between the APOE-
ε4 negative and positive groups (p’s > 0.05) on these measures. 
 
Episodic Memory Performance 
 
Group comparisons of RAVLT episodic memory performance are 
shown in Table 1. Significant group differences emerged for all RAVLT 
measures with large effect sizes: trials 1-5 [F(2, 127) = 38.24, p < 
0.001, 𝜂𝜂𝑝𝑝2 = 0.376], immediate recall [F(2, 127) = 39.65, p < 0.001, 
𝜂𝜂𝑝𝑝
2 = 0.384], and delayed recall [F(2, 127) = 52.06, p < 0.001, 𝜂𝜂𝑝𝑝2 = 
0.451]. The aMCI group had significantly lower performance on all 
three RAVLT measures compared to APOE-ε4 negative and positive 
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groups (p’s < 0.001). In addition, post-hoc analyses revealed that the 
APOE-ε4 positive group had significantly lower scores on RAVLT recall 
measures compared to the APOE-ε4 negative group with medium 
effect sizes: immediate recall (p = 0.007; d = 0.63); delayed recall (p 
= 0.047; d = 0.49). 
 
Paced Finger-Tapping Task Performance 
 
Group comparisons of PFTT performance are shown in Table 1 
and depicted in Figure 1. As predicted, significant group differences in 
IIV (SD-ITI) emerged [F(2, 127) = 3.66, p = 0.029, ηp 
2 = 0.054], despite equal mean level performance (M-ITI) [F(2, 127) 
= 0.93, p = 0.399, 𝜂𝜂𝑝𝑝2 = 0.014]. Post-hoc analyses revealed that aMCI 
participants had significantly greater IIV on the PFTT compared to the 
APOE-ε4 negative group (p = 0.030, d = 0.67), and a marginally 
significant greater IIV score compared to the APOE-ε4 positive group 
(p = 0.069, d = 0.72). Effects sizes are in the medium range for both 
comparisons, and the relatively small sample size of the APOE-ε4 
positive group most likely explains the attenuated group difference 
between the MCI group and the APOE-ε4 positive group. However, 
there were no group differences in IIV between APOE-ε4 negative and 
positive groups in post-hoc analyses (p = 0.997, d = 0.07). 
Nonparametric analyses using Kruskal-Wallis tests and follow-up 
Mann-Whitney tests (not shown) yielded similar results. 
 
(Place Table 1 here) 
(Place Figure 1 here) 
 
Correlational Analyses 
 
Results of partial correlational analyses (age as a covariate) between 
PFTT and RAVLT measures across groups are shown in Table 2. As 
predicted, significant negative relationships emerged between SD-ITI 
and all three RAVLT measures: trials 1-5 (r = -0.207; p = 0.019), 
immediate recall (r = -0.220; p = 0.012), and delayed recall (r = -
0.209; p = 0.017). Increased IIV was associated with lower memory 
scores. In contrast, PFTT mean level performance (MITI) was 
significantly correlated only with RAVLT immediate recall (r = 0.205; p 
= 0.020). Partial correlations between PFTT and RAVLT measures were 
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also examined for each group separately (not shown). Within the aMCI 
group, significant negative relationships emerged between SD-ITI and 
RAVLT trials 1-5 (r = -0.545; p = 0.007) and delayed recall (r = -
0.485; p = 0.019). Increased variability was associated with lower 
memory scores. In contrast, no significant correlations emerged 
between PFTT and RAVLT measures for the APOE-ε4 positive or APOE-
ε4 negative groups. 
 
(Place Table 2 here) 
 
Discussion 
 
The purpose of this study was to examine the performance of 
healthy elders with and without the APOE-ε4 allele and an aMCI group 
on a measure of motor performance, the PFTT. We were particularly 
interested in the potential differences on a measure of IIV in 
distinguishing between the three groups. In the context of similar 
mean ITI accuracy across groups, we found motor timing IIV to be 
greater for the aMCI group compared to both groups of cognitively 
intact elders. However, we found no significant group differences 
between asymptomatic APOE-ε4 non-carriers and carriers in motor 
timing ITI mean accuracy or IIV. We also found that poorer 
performance on RAVLT indices was associated with higher IIV, 
particularly in the aMCI group. 
 
As expected, the aMCI group demonstrated significantly poorer 
neuropsychological test performance compared to cognitively intact 
groups (APOE-ε4 carriers and non-carriers) on all RAVLT measures 
(Petersen et al., 1999). We also found that cognitively intact APOE-ε4 
carriers had significantly poorer performance on RAVLT indices than 
non-carriers, consistent with research showing poorer episodic 
memory performance during this clinically asymptomatic stage (El Haj 
et al., 2016; Twamley, Ropacki, & Bondi, 2006). 
 
The results reported here are consistent with several recent 
studies showing that increased IIV in performance on a variety of fine 
and gross motor tasks (i.e., finger tapping, walking speed, etc.) may 
constitute a useful cognitive marker for the transition from cognitively 
intact to the prodromal aMCI stage (Buracchio, Dodge, Howieson, 
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Wasserman, & Kaye, 2010; Dodge et al., 2012; Verghese et al., 
2007). Further, these findings emerged in the context of equivalent 
mean level motor timing performance across groups, which suggests 
that IIV indices may provide valuable information above and beyond 
traditional measures of cognitive performance based on mean scores 
(Hultsch, MacDonald, Hunter, Levy-Bencheton, & Strauss, 2000). 
Reliance on the standard approach of comparing mean level 
performance between groups would not have detected differences in 
motor timing variability at the prodromal aMCI stage in our sample. 
 
Post-hoc analyses revealed that aMCI participants had 
significantly greater IIV on the PFTT compared to APOE-ε4 non-carriers 
and a marginally significant greater IIV score compared to APOE-ε4 
carriers; however, effect sizes are in the medium range for both 
comparisons with a slightly stronger effect for the latter comparison. 
The relatively small sample size of the APOE-ε4 positive group most 
likely explains this attenuated group difference. 
 
Consistent with previous studies, we found no significant 
differences in performance variability on the PFTT between cognitively 
intact APOE-ε4 carriers and non-carriers. Duchek et al. (2009) also did 
not find significant differences in IIV between healthy APOE-ε4 carriers 
and non-carriers using three different selective attention tasks, except 
for a single score on incongruent trials of the Stroop task. Kalin et al. 
(2014) reported a very small effect size difference between healthy 
elders with the APOE-ε4 allele compared to those without the allele for 
within-domain IIV in tasks of executive functioning. Nevertheless, 
longitudinal data is necessary to more clearly determine the predictive 
value of IIV for progression to the MCI stage and dementia. 
 
It is important to note that, while the aMCI group exhibited 
significantly greater motor timing IIV compared to cognitively intact 
elders, the magnitude of this difference was relatively small compared 
to the large effect sizes that emerged for the same group comparisons 
of episodic memory performances. Further, in contrast with episodic 
memory performance, which was able to distinguish between healthy 
APOE-ε4 carriers and non-carriers, IIV on the PFTT was equal for both 
groups of cognitively intact elders. This suggests that episodic memory 
performance, in comparison to motor timing IIV, continues to serve as 
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the most reliable predictor of cognitive decline during the 
asymptomatic preclinical stage of AD. 
 
Age-related differences in IIV may be most apparent on 
speeded tasks that place increased demands on executive functioning 
or working memory (Dixon et al., 2007), or other cognitively complex 
tasks (Hultsch et al., 2000; Strauss, Bielak, Bunce, Hunter, & Hultsch, 
2007). It is possible that IIV on the PFTT did not recruit sufficiently 
complex executive function and attentional control mechanisms to 
elicit strong IIV differences between cognitively intact APOE-ε4 carriers 
and non-carriers. For example, it may be necessary to employ tasks 
that have stronger working memory demands. In contrast, MCI is 
characterized by attentional lapses, failures of inhibition, and reduced 
executive control, all of which can serve as mechanisms for increased 
IIV. 
 
Viewed from a neurological perspective, there may be particular 
brain regions that are important in maintaining low response 
variability. Recent neuroimaging studies indicate that increased IIV is 
associated with neurophysiological deterioration within frontal 
systems, particularly in white matter. For example, Bunce et al. (2007) 
found that white matter hyperintensities were significantly correlated 
with IIV on speeded cognitive tasks in healthy older adults (ages 60-
64). Importantly, this relationship was unique to white matter integrity 
in the frontal lobes, demonstrating that these neural pathways play a 
key role in increased IIV. Functional MRI studies have also shown 
important relationships between the frontal lobes and increased IIV 
(Bellgrove, Hester, & Garavan, 2004). Further, alterations in select 
neurotransmitters, such as neuromodulatory deficiencies in dopamine, 
may underscore increased IIV in cognitive performance (Hultsch et al., 
2002; Li, Lindenberger, & Sikstrom, 2001; Rabbitt, Osman, Moore, & 
Stollery, 2001). While subtle alterations within frontal systems may be 
detectable via imaging techniques, our results suggest that these 
changes are not yet apparent through behavioral measures of IIV in 
either APOE-ε4 carrier or non-carrier asymptomatic individuals. 
 
There are limitations that may have obscured the potential IIV 
differences in comparison of the APOE-ε4 carriers and non-carriers 
prior to symptom onset. First, we employed only a single measure of 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Journal of Clinical and Experimental Neuropsychology, Vol 39, No. 9 (2017): pg. 866-875. DOI. This article is © Taylor & 
Francis (Routledge) and permission has been granted for this version to appear in e-Publications@Marquette. Taylor & 
Francis (Routledge) does not grant permission for this article to be further copied/distributed or hosted elsewhere 
without the express permission from Taylor & Francis (Routledge). 
14 
 
motor timing IIV (fine motor synchronization) to an external stimulus. 
Additional measures of motor timing and other indices of motor 
movement may provide a more nuanced assessment of motor 
variability. A broad motor performance battery including fine, gross, 
and complex tasks, in addition to measures of gait and ambulation, 
may prove useful in eliciting differences in asymptomatic elders with 
different genetic risk factors. 
 
Further, the PFTT may not have recruited sufficient cognitive 
complexity to distinguish between APOE-ε4 carriers and non-carriers. 
Assuming IIV is a frontally mediated process, as has been suggested 
(i.e., Bellgrove et al., 2004), then more complex executive tasks may 
prove better able to distinguish those at risk for AD. Specifically, tasks 
that tap aspects of attentional selection, inhibition, and switching may 
be considered for future studies, as such tasks appear to be 
particularly sensitive to MCI and early AD (Castel, Balota, Hutchison, 
Logan, & Yap, 2007; Spieler, Balota, & Faust, 1996). 
 
Ultimately, a longitudinal design is necessary to provide more 
definitive statements about the predictive utility of increased IIV in 
individuals with genetic susceptibility to AD. With regard to sampling 
procedures, cognitively intact study participants were volunteers living 
independently in the local community and were highly educated, 
mostly Caucasian (98.5%), and predominantly female (70.5%). These 
factors limit the generalizability of our findings, and future 
investigations would benefit from inclusion of a more heterogeneous 
sample. 
 
Conclusions 
 
Overall, findings from this study suggest that increased IIV on a 
fine motor synchronization task is evident at the aMCI stage, but IIV 
differences did not distinguish between APOE-ε4 allele carriers and 
non-carriers during the preclinical stage. Further, motor timing IIV 
appears to have weaker capacity to distinguish between individuals at 
AD risk compared to episodic memory performance, a well-established 
predictor of cognitive decline. More definitive findings from longitudinal 
studies and the investigation of a broader repertoire of motor functions 
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are needed to determine the value of IIV measurement in predicting 
cognitive decline in asymptomatic elders.  
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Table 1. Demographics and Cognitive Screening, Episodic Memory, and 
Paced Finger-Tapping Performances by Group 
 
Note. ε4 = apolipoprotein E-epsilon 4; MCI = mild cognitive impairment; 
MMSE = Mini-Mental State Examination; DRS-2 = Dementia Rating Scale-2nd 
Edition; RAVLT = Rey Auditory Verbal Learning Test; ms = milliseconds; ITI = 
inter-tap interval. ^9 ε4–, 15 ε4+. aPearson Chi-Square Test. bCramer’s V . 
cANOVA results using standardized residual scores based on regression with 
age as a predictor. dANOVA results using standardized residual scores based 
on regression with age and education as predictors. 
 
Table 2. Pearson Correlationsa between Paced Finger-Tapping and Episodic 
Memory Test Performances across Groups 
 
Note. RAVLT = Rey Auditory Verbal Learning Test; M-ITI = mean inter-tap 
interval; SD-ITI = standard deviation of inter-tap interval. aPartial correlations 
(covariate: age). * p < .05. 
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Figure Legend 
 
Figure 1. Paced finger-tapping performance by group. Left panel presents 
mean accuracy, represented by mean inter-tap interval (ITI) minus the target 
ITI (333 milliseconds). Right panel presents mean standard deviation of the 
ITI, a measure of intraindividual variability. Error bars represent standard 
error of the mean. ε4 = apolipoprotein E-epsilon 4; MCI = mild cognitive 
impairment; ITI = inter-tap interval. 
* p < .05. 
 
